Maintenance therapy with CC-486 extended overall survival of adults with the blood cancer acute myeloid leukemia (AML) in a large clinical trial. CC-486 is a pill form of another cancer therapy called azacitidine (Vidaza).
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2FRORNf
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2FRORNf